glp 1 agonist cardioprotective The Potential Role of GLP-1 Analogues in Cardiovascular Disease O Unveiling the Potential Role of

Background Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain

In response to shortages, the FDA allowed use of compounded GLP-1 drugs. What are “compounded drugs? Most prescription medications are approved by the FDA and manufactured by drug companies.Compoundeddrugs are made by licensed pharmacists or physicians who […]

Diabetes mellitus, a condition that significantly elevates the incidence and mortality risks associated with cardiovascular diseases, exacerbates the disease burden in China

Eli Lilly have a new, once-monthly GLP1/GIP agonist (Brenipatide) and they're running some fascinating trials with it Smoking cessation, bipolar disorder, schizophrenia, opioid use disorder, depression, alcohol use disorder, and asthma

Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects

Metabolic Benefits: Along with weight loss, it has shown promising results in treating Type 2 diabetes, with some studies showing hemoglobin A1c reductions